363 related articles for article (PubMed ID: 18842607)
1. Sustained effects of ecstasy on the human brain: a prospective neuroimaging study in novel users.
de Win MM; Jager G; Booij J; Reneman L; Schilt T; Lavini C; Olabarriaga SD; den Heeten GJ; van den Brink W
Brain; 2008 Nov; 131(Pt 11):2936-45. PubMed ID: 18842607
[TBL] [Abstract][Full Text] [Related]
2. A prospective cohort study on sustained effects of low-dose ecstasy use on the brain in new ecstasy users.
de Win MM; Reneman L; Jager G; Vlieger EJ; Olabarriaga SD; Lavini C; Bisschops I; Majoie CB; Booij J; den Heeten GJ; van den Brink W
Neuropsychopharmacology; 2007 Feb; 32(2):458-70. PubMed ID: 17077812
[TBL] [Abstract][Full Text] [Related]
3. Mood, cognition and serotonin transporter availability in current and former ecstasy (MDMA) users: the longitudinal perspective.
Thomasius R; Zapletalova P; Petersen K; Buchert R; Andresen B; Wartberg L; Nebeling B; Schmoldt A
J Psychopharmacol; 2006 Mar; 20(2):211-25. PubMed ID: 16510479
[TBL] [Abstract][Full Text] [Related]
4. Neuroimaging findings with MDMA/ecstasy: technical aspects, conceptual issues and future prospects.
Reneman L; de Win MM; van den Brink W; Booij J; den Heeten GJ
J Psychopharmacol; 2006 Mar; 20(2):164-75. PubMed ID: 16510475
[TBL] [Abstract][Full Text] [Related]
5. Intensity dependence of auditory evoked dipole source activity in polydrug ecstasy users: evidence from an 18 months longitudinal study.
Daumann J; Till B; Fischermann T; Rezk M; Gouzoulis-Mayfrank E
J Psychopharmacol; 2006 Mar; 20(2):236-44. PubMed ID: 16510481
[TBL] [Abstract][Full Text] [Related]
6. Neurotoxic effects of ecstasy on the thalamus.
de Win MM; Jager G; Booij J; Reneman L; Schilt T; Lavini C; Olabarriaga SD; Ramsey NF; Heeten GJ; van den Brink W
Br J Psychiatry; 2008 Oct; 193(4):289-96. PubMed ID: 18827290
[TBL] [Abstract][Full Text] [Related]
7. Cognitive performance in recreational ecstasy polydrug users: a two-year follow-up study.
de Sola Llopis S; Miguelez-Pan M; Peña-Casanova J; Poudevida S; Farré M; Pacifici R; Böhm P; Abanades S; Verdejo García A; Langohr K; Zuccaro P; de la Torre R
J Psychopharmacol; 2008 Jul; 22(5):498-510. PubMed ID: 18208910
[TBL] [Abstract][Full Text] [Related]
8. Neural mechanisms of working memory in ecstasy (MDMA) users who continue or discontinue ecstasy and amphetamine use: evidence from an 18-month longitudinal functional magnetic resonance imaging study.
Daumann J; Fischermann T; Heekeren K; Thron A; Gouzoulis-Mayfrank E
Biol Psychiatry; 2004 Sep; 56(5):349-55. PubMed ID: 15336517
[TBL] [Abstract][Full Text] [Related]
9. Ecstasy use and self-reported depression, impulsivity, and sensation seeking: a prospective cohort study.
de Win MM; Schilt T; Reneman L; Vervaeke H; Jager G; Dijkink S; Booij J; van den Brink W
J Psychopharmacol; 2006 Mar; 20(2):226-35. PubMed ID: 16510480
[TBL] [Abstract][Full Text] [Related]
10. Effects of ecstasy (MDMA) on the brain in abstinent users: initial observations with diffusion and perfusion MR imaging.
Reneman L; Majoie CB; Habraken JB; den Heeten GJ
Radiology; 2001 Sep; 220(3):611-7. PubMed ID: 11526257
[TBL] [Abstract][Full Text] [Related]
11. Potential long-term effects of MDMA on the basal ganglia-thalamocortical circuit: a proton MR spectroscopy and diffusion-tensor imaging study.
Liu HS; Chou MC; Chung HW; Cho NY; Chiang SW; Wang CY; Kao HW; Huang GS; Chen CY
Radiology; 2011 Aug; 260(2):531-40. PubMed ID: 21633053
[TBL] [Abstract][Full Text] [Related]
12. Neurotoxicity of methylenedioxyamphetamines (MDMA; ecstasy) in humans: how strong is the evidence for persistent brain damage?
Gouzoulis-Mayfrank E; Daumann J
Addiction; 2006 Mar; 101(3):348-61. PubMed ID: 16499508
[TBL] [Abstract][Full Text] [Related]
13. Proton magnetic resonance spectroscopy in ecstasy (MDMA) users.
Daumann J; Fischermann T; Pilatus U; Thron A; Moeller-Hartmann W; Gouzoulis-Mayfrank E
Neurosci Lett; 2004 May; 362(2):113-6. PubMed ID: 15193766
[TBL] [Abstract][Full Text] [Related]
14. The Netherlands XTC Toxicity (NeXT) study: objectives and methods of a study investigating causality, course, and clinical relevance.
De Win MM; Jager G; Vervaeke HK; Schilt T; Reneman L; Booij J; Verhulst FC; Den Heeten GJ; Ramsey NF; Korf DJ; Van den Brink W
Int J Methods Psychiatr Res; 2005; 14(4):167-85. PubMed ID: 16395871
[TBL] [Abstract][Full Text] [Related]
15. Learning and memory deficits in ecstasy users and their neural correlates during a face-learning task.
Roberts GM; Nestor L; Garavan H
Brain Res; 2009 Oct; 1292():71-81. PubMed ID: 19631624
[TBL] [Abstract][Full Text] [Related]
16. Experience of diffusion tensor imaging and 1H spectroscopy for outcome prediction in severe traumatic brain injury: Preliminary results.
Tollard E; Galanaud D; Perlbarg V; Sanchez-Pena P; Le Fur Y; Abdennour L; Cozzone P; Lehericy S; Chiras J; Puybasset L
Crit Care Med; 2009 Apr; 37(4):1448-55. PubMed ID: 19242330
[TBL] [Abstract][Full Text] [Related]
17. MDMA in humans: factors which affect the neuropsychobiological profiles of recreational ecstasy users, the integrative role of bioenergetic stress.
Parrott AC
J Psychopharmacol; 2006 Mar; 20(2):147-63. PubMed ID: 16510474
[TBL] [Abstract][Full Text] [Related]
18. The sub-acute effects of recreational ecstasy (MDMA) use: a controlled study in humans.
Huxster JK; Pirona A; Morgan MJ
J Psychopharmacol; 2006 Mar; 20(2):281-90. PubMed ID: 16510486
[TBL] [Abstract][Full Text] [Related]
19. The confounding problem of polydrug use in recreational ecstasy/MDMA users: a brief overview.
Gouzoulis-Mayfrank E; Daumann J
J Psychopharmacol; 2006 Mar; 20(2):188-93. PubMed ID: 16510477
[TBL] [Abstract][Full Text] [Related]
20. Evidence of increased activation underlying cognitive control in ecstasy and cannabis users.
Roberts GM; Garavan H
Neuroimage; 2010 Aug; 52(2):429-35. PubMed ID: 20417713
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
